Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
Shu Chen Wei
Intest Res. 2016;14(4):293-294.   Published online 2016 Oct 17     DOI: https://doi.org/10.5217/ir.2016.14.4.293
Citations to this article as recorded by Crossref logo
Monitoring Disease Activity: How and When?
Kang-Moon Lee
The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
Journal of the Formosan Medical Association.2018;[Epub]     CrossRef
Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
Shu-Chen Wei, Chien-Chih Tung, Meng-Tzu Weng, Jau-Min Wong
Intestinal Research.2018; 16(4): 546.     CrossRef
Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
Young-Ho Kim
Intestinal Research.2018; 16(4): 507.     CrossRef
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
Sun-Ho Lee, Min-Ju Kim, Kiju Chang, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
BMC Gastroenterology.2017;[Epub]     CrossRef
Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
Hyun Jung Lee, Jae Hee Cheon
Intestinal Research.2017; 15(3): 311.     CrossRef